Use Case · Life Sciences & Pharma
Asset & Software Compliance for GxP Systems
Building an accurate, defensible inventory of the hardware and software supporting validated GxP systems — so audits and license true-ups stop starting with a spreadsheet reconciliation.
Where this shows up
In regulated environments, an incomplete or inaccurate asset inventory isn’t just an IT hygiene problem — it’s an audit and validation risk. Many life sciences IT teams can’t confidently answer which hardware and software versions sit behind a given validated process, or prove that patch and configuration state matches what was documented.
How we approach it
- Establish a single source of truth for hardware and software assets tied to GxP-relevant systems.
- Reconcile discovered software against license entitlements to close compliance and true-up gaps.
- Tie asset records to validation documentation so configuration drift is visible, not discovered during an audit.
- Set up ongoing discovery and reconciliation cadence instead of a one-time cleanup.
What changes
- An asset inventory that holds up under audit scrutiny
- Reduced license compliance and true-up exposure
- Configuration drift caught before it becomes a validation finding
Working through something similar?
